A Novel Method for Unambiguous, Quantitative Detection of Full-length and Truncated Thioredoxin from Complex Biological Samples

Case ID:
C10475
Unmet Need: Thioredoxin (TRX) is an essential protein that acts as antioxidant and can be used as a general marker of many different disease conditions involving oxidative stress. Currently, the level of thioredoxin is detected using ELISA methods. While potentially informative, there may be several problems inherent in this technique as this protein exists in full-length form (TRX) and truncated form (TRX80) in biological samples. TRX80 has additional properties that may promote several processes including chemoattraction, mitogenesis, and inflammation. Many ELISA methods do not measure TRX80, or may potentially be cross-reactive to TRX80 without accounting for this in obtained values. Since these two forms of the protein have been ascribed different functions, it is important to be able to monitor both forms in a highly quantitative way within the same sample.
Value Proposition:
  • Novel method to unambiguously and quantitatively distinguish TRX and TRX80 in complex biological samples
  • Samples are denatured and fully digested, thereby eliminating issues of protein/protein interactions
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
Detection and Quantitation of Full-length Thioredoxin (TRX) and Truncated Thioredoxin (TRX 80) in Complex Samples ORD: Ordinary Utility United States 12/953,053 8,512,963 11/23/2010 8/20/2013 11/25/2029 Granted
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Vera Sampels
vsampel2@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum